Developments Aspire files omnibus patent application with USPTO for drug delivery platform Aspire Biopharma Holdings (NASDAQ: ASBP) has announced the filing of an omnibus patent application with the USPTO for its sublingual drug delivery technology. According to Aspire, the technology is designed to enhance... October 6, 2025